Education
About Us
Working with TipRanks
Follow Us
Jacob Van Naarden Insider Profile
4 Followers
Jacob Van Naarden, COO at Loxo Oncology, holds 36.27K shares in Eli Lilly & Co (Ticker: LLY), holds 0.00 shares in Loxo Oncology (Ticker: LOXO).
Jacob Van Naarden Loxo Oncology (LOXO)COO
Loxo Oncology (LOXO)
COO
Not Ranked
Jacob Van Naarden has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Jacob Van Naarden's holdings
Insider Roles
EVP,Pres LLY Oncology&HdCorpBD
Roles that Jacob Van Naarden holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Jacob Van Naarden
Jacob Van Naarden's Trading History
Loxo Oncology
Feb 15, 2019
―
Uninformative Sell
4.46M
$0.00
Eli Lilly & Co
Feb 11, 2026
EVP,Pres LLY Oncology&HdCorpBD
Uninformative Buy
5.08M
$33.30M
List of latest transactions for each holding click on a transaction to see Jacob Van Naarden's performance on stock
You May Also Like
Jacob Van Naarden insider profile FAQ
What is the percentage of profitable transactions made by Jacob Van Naarden?
The percentage of profitable transactions made by Jacob Van Naarden is ―.
What is the average return per transaction made by Jacob Van Naarden?
The average return per transaction made by Jacob Van Naarden is ―.
What stocks does Jacob Van Naarden hold?
Jacob Van Naarden holds: LOXO, LLY stocks.
What was Jacob Van Naarden’s latest transaction?
Jacob Van Naarden latest transaction was an Uninformative Buy of $5.08M.
What was Jacob Van Naarden's most profitable transaction?
Jacob Van Naarden’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Jacob Van Naarden's role in Loxo Oncology?
Jacob Van Naarden's role in Loxo Oncology is COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.